4//SEC Filing
Daly David 4
Accession 0001209191-17-048408
CIK 0001488613other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:06 PM ET
Size
9.1 KB
Accession
0001209191-17-048408
Insider Transaction Report
Form 4
Daly David
Chief Commercial Officer
Transactions
- Sale
Common Stock
2017-08-09$39.50/sh−46,872$1,851,444→ 116,261 total - Exercise/Conversion
Stock Option (right to buy)
2017-08-09−46,872→ 28,128 totalExercise: $22.24Exp: 2024-12-05→ Common Stock (46,872 underlying) - Exercise/Conversion
Common Stock
2017-08-09$22.24/sh+46,872$1,042,433→ 163,133 total
Footnotes (2)
- [F1]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $40.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F2]This option was granted on December 5, 2014 and is exercisable (i) with respect to 25% of the shares subject to the options, on November 30, 2015, and (ii) with respect to 6.25% of the shares subject to the option, on each subsequent three month period beginning February 28, 2016 until fully vested.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeother
Related Parties
1- filerCIK 0001320267
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:06 PM ET
- Size
- 9.1 KB